Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margret B Einarson

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancer Research|October 25, 2017
miR-6883 Family miRNAs Target CDK4/6 to Induce G<sub>1</sub> Phase Cell-Cycle Arrest in Colon Cancer CellsAmriti R Lulla, Michael J Slifker, Yan Zhou, et al.
Plos One|October 12, 2012
An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancerGeetika Sethi, Harsh B Pathak, Hong Zhang, et al.
Nature Communications|April 3, 2025
Inhibiting acute, axonal DLK palmitoylation is neuroprotective and avoids deleterious effects of cell-wide DLK inhibitionXiaotian Zhang, Heykyeong Jeong, Jingwen Niu, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Novel inhibitors of acute, axonal DLK palmitoylation are neuroprotective and avoid the deleterious side effects of cell-wide DLK inhibitionXiaotian Zhang, Heykyeong Jeong, Jingwen Niu, et al.
Cancers|February 5, 2020
Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck CancerAlexander Y Deneka, Margret B Einarson, John Bennett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2013
Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responsesMichael Brusilovsky, Moti Cordoba, Benyamin Rosental, et al.
Scientific Reports|March 8, 2019
Identification of Novel Inhibitors of DLK Palmitoylation and Signaling by High Content ScreeningDale D O Martin, Prasad S Kanuparthi, Sabrina M Holland, et al.
Oncotarget|November 19, 2016
Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatinAnna V Gaponova, Alexander Y Deneka, Tim N Beck, et al.
Head & Neck|June 28, 2013
Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancerCarolyn Y Fang, Brian L Egleston, John A Ridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2019
Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted DrugsAnna A Kiseleva, Vladislav A Korobeynikov, Anna S Nikonova, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer Research|October 25, 2017
miR-6883 Family miRNAs Target CDK4/6 to Induce G<sub>1</sub> Phase Cell-Cycle Arrest in Colon Cancer CellsAmriti R Lulla, Michael J Slifker, Yan Zhou, et al.
Plos One|October 12, 2012
An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancerGeetika Sethi, Harsh B Pathak, Hong Zhang, et al.
Nature Communications|April 3, 2025
Inhibiting acute, axonal DLK palmitoylation is neuroprotective and avoids deleterious effects of cell-wide DLK inhibitionXiaotian Zhang, Heykyeong Jeong, Jingwen Niu, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Novel inhibitors of acute, axonal DLK palmitoylation are neuroprotective and avoid the deleterious side effects of cell-wide DLK inhibitionXiaotian Zhang, Heykyeong Jeong, Jingwen Niu, et al.
Cancers|February 5, 2020
Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck CancerAlexander Y Deneka, Margret B Einarson, John Bennett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2013
Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responsesMichael Brusilovsky, Moti Cordoba, Benyamin Rosental, et al.
Scientific Reports|March 8, 2019
Identification of Novel Inhibitors of DLK Palmitoylation and Signaling by High Content ScreeningDale D O Martin, Prasad S Kanuparthi, Sabrina M Holland, et al.
Oncotarget|November 19, 2016
Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatinAnna V Gaponova, Alexander Y Deneka, Tim N Beck, et al.
Head & Neck|June 28, 2013
Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancerCarolyn Y Fang, Brian L Egleston, John A Ridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2019
Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted DrugsAnna A Kiseleva, Vladislav A Korobeynikov, Anna S Nikonova, et al.
Pageof 3